ZACHARY LANDERS: Open Payments
NPI 1811661010 · OWOSSO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$640 in 35 payments from 10 companies in 2025. Trend: 2023 $1,170 · 2024 $1,202 · 2025 $640
Food & beverage: $627Education: $14
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $284 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $71 |
| Janssen Biotech, Inc. | 3 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| Gilead Sciences, Inc. | 3 | $47 |
| Janssen Scientific Affairs, LLC | 1 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Madrigal Pharmaceuticals | 1 | $24 |
| Ardelyx, Inc. | 1 | $19 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
Products named: RINVOQ, TREMFYA, XIFAXAN, SKYRIZI, MAVYRET, ENTYVIO, DUPIXENT, REZDIFFRA.
Industry payments across MI — which companies pay providers there.
